Total Funding
20
29
Total FundingPost-IPO Equity raised
Growth Score 20 in past quarter
0 pts
Heat Score 29 in past quarter
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
198143
Anpac Bio-Medical Science is a biotechnology company focusing on early cancer screening and detection.
Herbert Yu: Co-Founder & Chief Science Officer
Drisha Leggitt: Vice President, Business Development
About the Company
Anpac Bio-Medical Science is a biotechnology company that focuses on early cancer screening and detection. A variety of cancer screening and detection tests are carried out by AnPac Bio, including tests for biochemistry, immunology, genomics, and CDA (Cancer Differentiation Analysis). AnPaC Bio seeks to unite experts from various fields in order to
create, disseminate, and implement accessible early disease detection tools.